Company: APM
Filing Date: 2025-12-05
Form Type: 424B5
Source: 0001213900-25-118752
Chunk: 348

Company: Aptorum Group Ltd
Filing Date: 2025-12-05
Form: 424B5
Chunk 348
---
otech company developing and commercializing chemosaturation treatments for cancer. From 2010-2011 Dr. Philips served on the board of
directors of China Yongxin Phamaceuticals (OTCBB:CYXN) a leading retailer, wholesaler and distributor of pharmaceuticals and health and
beauty products in Northeastern China. From 2003-2006 Dr. Philips was COO/Chief Financial Officer at NexGenix Pharmaceuticals. She held
a variety of executive positions at Corning, Incorporated, from 1997-2002. Dr. Philips served in the Clinton Administration both as a
Fellow in the White House Office of Science and Technology Policy and as a Presidential Appointee in the position of Senior Policy Advisor
to Sec. Ronald Brown in the Dept. of Commerce. Dr. Philips was on the Faculty of Cornell University in the Dept. of Chemistry from 1987-1993.
She was an NIH Post-Doctoral Fellow at the University of Chicago, holds a PhD in Chemistry from the University of California, Berkeley
and an MBA from Cornell University. Dr. Philips provides the board with significant expertise in growth of early stage companies, development
and launch of devices, including for biomedical applications, as well as a strong history of service on board committees.

Cybersecurity Governance

Cybersecurity will be an important part of our
risk management processes and an area of focus for our Board and management. The Audit Committee will be responsible for the oversight
of risks from cybersecurity threats. Members of the Audit Committee will receive updates on a quarterly basis from senior management,
regarding matters of cybersecurity. This includes existing and new cybersecurity risks, status on how management is addressing and/or
mitigating those risks, cybersecurity and data privacy incidents (if any) and status on key information security initiatives. Our Board
members will also engage in ad hoc conversations with management on cybersecurity-related news events and discuss any updates to our cybersecurity
risk management and strategy programs.

<div align='center'>201

Compensation of Company Executive Officers and Directors</div>

The following table sets forth
all cash compensation paid by us, as well as certain other compensation paid or accrued, in fiscal 2024 to each of the following named
executive officers. The total amount was $0.1 million in 2024. This amount does not include business travel, relocation, professional
and business association dues, and expenses reimbursed to such persons, and other benefits commonly reimbursed or paid by